Melinta Therapeutics, Llc
Clinical trials sponsored by Melinta Therapeutics, Llc, explained in plain language.
-
One-shot antibiotic shows promise for kids with skin infections
Disease control CompletedThis study tested a single-dose antibiotic called oritavancin in 118 children aged 3 months to under 12 years with bacterial skin infections. The goal was to see if the drug is safe and tolerable. Researchers compared two versions of the drug and monitored side effects and how we…
Phase: PHASE2 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated May 26, 2026 12:05 UTC
-
New antibiotic tested in kids: a step toward better infection control
Disease control CompletedThis early-stage study tested a single dose of oritavancin in 41 children under 18 with suspected or confirmed bacterial infections. The goal was to see how the drug moves through the body and whether it is safe. Results will help guide future use of this antibiotic in pediatric …
Phase: PHASE1 • Sponsor: Melinta Therapeutics, LLC • Aim: Disease control
Last updated May 13, 2026 16:04 UTC